Notice
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Debate Session 5 : Insights from DOSE and gaps in evidence with diuretic therapy (Alice MASCETTE)
- document 1 document 2 document 3
- niveau 1 niveau 2 niveau 3
Descriptif
MODIGLIANI Debate Session 5 - Saturday December 1st, 2012
NOVEL DIURETIC STRATEGIES IN HEART FAILURE
Chairpersons: Keld KJELDSEN, Copenhagen, DEN - Gian Paolo ROSSI, Padua, ITA
Webcast: Patrick ROSSIGNOL, Nancy, FRA
➢ Clinical congestion due to volume overload is the main cause of hospitalization for patients with HF and is an important therapeutic target. Failure to achieve effective and rapid correction of this condition in many patients hospitalized for HF results in prolongation of hospital stay and unfavorable after-discharge outcome.
➢ Loop diuretics, though often effective for treating congestion, have significant limitations. Discovering ways to optimize exposure to loop diuretics, achieving effective decongestion while protecting renal function, is an important goal of current clinical research in HF.
➢ Vasopressin antagonists are effective in removing large amounts of water, but not salt, in HF. The EVEREST trial in unselected acute systolic heart failure did not show benefit on CV outcomes and only a modest benefit on dyspnea. Whether vaptans in HF are still a viable option is an important question. Better targeting specific vasopressin receptors with highly selective agents, better profiling of patients more likely to benefit, combination with mineralocorticoid receptor antagonists are options that are worth exploring.
➢ Aquapharesis (Ultrafiltration: UF) has been shown to be a safe and effective therapeutic modality for correction of volume overload in hospitalized patients with HF, not responding to intravenous diuretics and vasoactive medications. Should UF replace intravenous diuretics as a first-line therapy for patients with hypervolemia admitted for HF? The validity of such a concept is being examined in the NHLBI larger CARRESS study.
Session program:
Insights from DOSE and gaps in evidence with diuretic therapy
Speaker: Alice MASCETTE, NHLBI, USA
The Vaptans story post-EVEREST.
What is next? ACTIVATE, TACTICS and BALANCE trials
Speaker: Michael FELKER, Durham, USA
Discussant: William T. ABRAHAM, Colombus, USA
Ultrafiltration for acute cardiorenal syndrome in heart failure. UNLOAD and AVOID-HF and CARRESS trial
Speaker: Gian Paolo ROSSI, Padua, ITA
Debate: New diuretic modalities: Remaining gaps in evidence or ready for clinical use?
Thème
Documentation
Liens
Dans la même collection
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is hear…
DELIARGYRIS Efthymios
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Industry perspectiv…
WOEHRLE Holger
MODIGLIANI Lunch Debate Session 1 - Friday November 30, 2012 THE DEVICE THERAPY TRIALISTS WORKSHOP Chairpersons: Gaetano DE FERRARI, Pavia, ITA - Ileana PIÑA, New York, USA Webcast: Tariq AHMAD,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is hear…
PRASAD Krishna
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : Different doses, differe…
VERHEUGT Freek
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Non randomized and/…
POCOCK Stuart J.
MODIGLIANI Lunch Debate Session 1 - Friday November 30, 2012 THE DEVICE THERAPY TRIALISTS WORKSHOP Chairpersons: Gaetano DE FERRARI, Pavia, ITA - Ileana PIÑA, New York, USA Webcast: Tariq AHMAD,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is hear…
ZANNAD Faiez
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : How to secure the optima…
GIBSON Michael
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : Industry viewpoint (Joer…
KOECK Jean-Louis
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 2 : Well Established Methods…
KOENIG Wolfgang
MODIGLIANI Workshop 2 - Friday November 30, 2012 : ATHEROSCLEROSIS IMAGING IN CLINICAL TRIALS Facilitating the discovery of effective therapies Chairpersons: Jagat NARULA, New York, USA - Ahmed
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Options of and alte…
ABRAHAM William T.
MODIGLIANI Lunch Debate Session 1 - Friday November 30, 2012 THE DEVICE THERAPY TRIALISTS WORKSHOP Chairpersons: Gaetano DE FERRARI, Pavia, ITA - Ileana PIÑA, New York, USA Webcast: Tariq AHMAD,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : How to secure the optima…
GELLER Nancy L.
MODIGLIANI Workshop 1 - Friday November 30, 2012 : THE THROMBOSIS TRIALISTS WORKSHOP DOSE AND TARGET PATIENT POPULATIONS ISSUES Chairpersons: Peter CLEMMENSEN, Copenhagen, DEN - George-Andrei DAN,
-
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Debate Session 5 : Ultrafiltration fo…
ROSSI Gian Paolo
MODIGLIANI Debate Session 5 - Saturday December 1st, 2012 NOVEL DIURETIC STRATEGIES IN HEART FAILURE Chairpersons: Keld KJELDSEN, Copenhagen, DEN - Gian Paolo ROSSI, Padua, ITA Webcast: Patrick
Sur le même thème
-
La naissance de la médecine scientifique (par Pierre Corvol)
CORVOL Pierre
MONTENOT Jean
La naissance de la médecine scientifique Dans La Maison Nuncingen (1837), Balzac met en scène une conversation entre quatre journalistes échauffés par un bon repas. L’un des commensaux, Émile
-
Prévention de l'accident vasculaire cérébral
Chaque année, en France, près de 125 000 cas d'AVC -- Accident Vasculaire Cérébral -- sont recensés. Avec les récidives, ce chiffre augmente de 25 % L' AVC représente la 1ère cause de handicap et
-
Du coté de chez...Michel Haïssaguerre
GLOINEC Yves
PRE Nadège
Inspiré du questionnaire de Proust, cet entretien plus intimiste engage une réflexion sur Michel Haïssaguerre en tant qu’homme et non plus en tant que cardiologue. Ce face-à-face permet de
-
Michel Haïssaguerre, entre rythmes et musicalité
GLOINEC Yves
PRE Nadège
A l’occasion de la création de l’Institut Hospitalo-Universitaire LIRYC (Institut de Rythmologie et de Modélisation Cardiaque) dont il est à l’origine, le 2e volet de notre série Trip TIC
-
Cardio-vasculaire
GAY Bernard
GOSSE Philippe
DOUARD Hervé
SASSOUST Gérard
Journées Bordeaux Segalen 2013 - Formation Médicale Continue des Médecins Généralistes - Session Cardio-vasculaire
-
Syndrome d'aorte douloureuse
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
Hypertension artérielle
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
Myocardiopathies restrictives
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
La fonction systolique
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
Échographie de contraste
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
Infarctus du myocarde
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,
-
Prothèses valvulaires
LAFITTE Stéphane
COTTARRE-LAFITTE Marianne
RéANT Patricia
ROUDAUT Raymond
Ce cours vidéo est tiré du cédérom Échocardiographie Doppler (éd. 2011), comportant plus de trente leçons (Écho-doppler transthoracique, Fonction systolique, Valvulopathies, Myocardiopathies,